Skip to main content
. 2020 Feb 5;9(7):2454–2461. doi: 10.1002/cam4.2855

Figure 2.

Figure 2

Positivity for marker FAM19A4 and markers FAM19A4 and miR124‐2 combined (and/or) in cytology samples, in E4 negative and E4 positive LSIL/CIN1 lesions with diffuse p16 expression in at least the lower 1/3 of the epithelium (p16 ≥ 1)